Brought to you by:
Medtronic’s Endurant receives FDA labelling approval to remove rAAA treatment warning
Medtronic recently announced it has received Food and Drug Administration (FDA) labelling approval for the Endurant stent graft system, by adding ruptured abdominal aortic aneurysm (rAAA) clinical evidence and removing the rAAA treatment warning. A press release notes that this…
‘Critical’ importance of lifelong surveillance after EVAR headlines newly published 10-year ENGAGE data
Ten-year data highlight the long-term efficacy and durability of the Endurant stent graft (Medtronic) in abdominal aortic aneurysm (AAA) patients who survived beyond five years post-enrollment in the ENGAGE registry. However, researchers also draw attention to the incidence of late…
‘Excellent’ long-term results after EVAR using Endurant stent graft in 180 AAA patients
Results from a real-world experience over more than 10 years using the Endurant stent graft (Medtronic) demonstrate that it is safe and effective, with excellent long-term outcomes for abdominal aortic aneurysm (AAA) anatomy that falls both inside and outside instructions…